Menu

Novo Holdings co-leads $205 million Series A financing of Crystalys Therapeutics to transform treatment of gout

Article |

Stellar375Craft... 2mo ago
Novo Holdings co-leads $205 million Series A financing of Crystalys Therapeutics to transform treatment of gout

Financing to support global Phase 3 development of dotinurad, Crystalys' next-generation, oral URAT1 inhibitor with the potential for...

Comments (0)

Newest

No comments yet.